Skip to content

Built to deliver uncommon insight.

Home
Team
Events
Contact
Ratings
Research

Chugai Pharm. (4519, Neutral): Looking beyond 1H results: Actemra facing new competition; ACE-910 and atezolizumab to drive growth, but valuations appear to discount it

Policy on Independence | Terms of Business | Privacy Policy

New Street Research LLP is registered in England and Wales No. OC303987. Registered office: 52 Cornhill, London, EC3V 3PD. New Street Research LLP is authorised and regulated in the conduct of its designated investment business in the United Kingdom by the Financial Conduct Authority.

© New Street Research LLP.
All Rights Reserved.
New Street Research, 52 Cornhill, London, EC3V 3PD

+44 20 7375 9111
info@newstreetresearch.com

Proudly powered by WordPress